Ricky Goldwasser

Morgan Stanley Upgrades Cigna On Humira Prospects

Diplomat Pharmacy Analysts Weigh Takeout Scenarios, Valuation After Going Concern Warning

Morgan Stanley: Buy The Dip In Livongo Health

Diplomat Pharmacy Analysts Weigh Takeout Scenarios, Valuation After Going Concern Warning

Morgan Stanley: Buy The Dip In Livongo Health

Sell-Side Mixed On Surging Livongo Health

CVS Turnaround Plan May Be 'Good Enough,' But Timeline Is The Question

Sell-Side Mixed On Surging Livongo Health

CVS Turnaround Plan May Be 'Good Enough,' But Timeline Is The Question

Analysts React To The Walgreens Q2 Earnings Miss

Analysts React To Diplomat Pharmacy's Q4 Earnings, Concerning Guidance

Ricky Goldwasser Recent News

Labs Are 'Relative Safe Havens' In Health Care Services, Morgan Stanley Says In Quest Diagnostics Upgrade

Core Growth At Inovalon Slackening, Morgan Stanley Says In Downgrade

Aetna Acquisition Puts CVS Growth Prospects Back In Good Health

Among Its Peers, Cardinal Health Could Be The Most Exposed To 'Amazon Risk'

Impending Headwinds Blow Walgreens Rating Down To Equal-Weight

Industry-Wide Changes Catch Up To Athenahealth Sooner Than Expected

Morgan Stanley Expects 'Above-Market Organic Growth' For Patheon, Initiates At Overweight

Morgan Stanley Downgrades Express Scripts To Underweight, Sees Greater Long-Term Pressure

Anthem Will Account For 21%-22% Of Express Scripts' Scripts In 2016, Says Morgan Stanley

Who Will Feel The Pain From Generic Drug Price Inflation?

Morgan Stanley Previews Walgreens' November Same-Store Sales

UPDATE: Morgan Stanley Upgraded McKesson and Introduced PT